Application of biological treatment of colorectal cancer outlook.docVIP

 PAGE \* MERGEFORMAT 14 Application of biological treatment of colorectal cancer outlook Abstract: The biological treatment of cancer has undergone a long and tortuous process of disappointing, it refers to the role of the host’s own immune system or give the animals the material to achieve the purpose of anti-tumor has been classified as among surgery, radiotherapy and chemotherapy to treat malignant tumors after the fourth important new tool, although there are some re-combination of biological treatment of the material is recognized as the standard treatment of certain malignant tumors, but the whole, the biological treatment of solid tumors is still in the exploration and pilot phase, efficacy was unsatisfactory, and there are many issues unresolved. Basically similar in colorectal cancer cases. In this paper, the current commonly used colorectal cancer several biological treatment, including interferon, interleukin (IL-α) and monoclonal antibody-directed treatment one by one, concise introduction and commentary. Body: the biological treatment of cancer has undergone a long and tortuous process of disappointing: early, people try to stimulate the body’s immune function to achieve its purpose of resistance to tumors, so called immunotherapy.With the understanding of tumor immunology, as well as re-combination of technology, there have been many new therapies, its meaning has become even more extensive, and therefore collectively referred to as biological therapy. And is considered as an addition to surgery, radiotherapy and chemotherapy, the fourth important new tool to treat malignant tumors. Biological treatment refers to the role of the host’s own immune system or give the animals the material to achieve the anti-tumor purposes. As more and more use of this treatment, so that the people of the host anti-cancer mechanisms have a better understanding, coupled with technological development, making it a sufficient number of lymph factor has